Home/Filings/4/0001643127-25-000006
4//SEC Filing

Krop Julie 4

Accession 0001643127-25-000006

CIK 0001401040other

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 4:32 PM ET

Size

5.8 KB

Accession

0001643127-25-000006

Insider Transaction Report

Form 4
Period: 2025-08-11
Krop Julie
Chief Marketing Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-08-11+450,000450,000 total
    Exercise: $4.58Exp: 2035-08-10Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001643127

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:32 PM ET
Size
5.8 KB